New Animal Model Shows Effective Treatment for Latent Tuberculosis

Professor Deepak Kaushal, Ph.D.
A major goal of tuberculosis (TB) research is to find a way to treat people with the latent (or inactive) form of the disease to keep them from developing symptomatic TB. A breakthrough study using a new animal model developed for this purpose showed a combination of two classes of antibiotics can wipe out this hidden threat. The study was published in the American Journal for Respiratory Clinical Care Medicine. SNPRC Director Deepak Kaushal, Ph.D., was the primary investigator of the study. To read more about this work, click here.
Distinguished Scientific Advisory Board Will Help Guide the Institute

As part of the Institute's strategic plan to grow the organization into the leading infectious disease research institute in the country, Texas Biomed has established an external scientific advisory board comprised of renowned experts. Five distinguished researchers have joined the newly-formed group to provide Texas Biomed with objective perspectives on matters relating to the Institute's research progress and priorities of its scientific programs. To read more about our new partners in progress, click here.
Founder's Council Teams up with Texas Biomed to Provide New Equipment for Scientists!

On December 4, 2019, the Founder's Councilbolstered by a generous challenge grant from the Tobin Endowment, granted a record $143,500 in grants to Texas Biomed researchers to acquire shared laboratory equipment. The purchases include:
* An iSeq 100 Sequencing System, an affordable and accessible bench top sequencer that allows sequencing of DNA and RNA with the push of a button.
Laparoscopy equipment for less invasive procedures on research animals.
Motic EASYSCAN infinity slide scanner which converts pathology slides to digital images for easy storage and analysis.
Click here to read more!
Vaccine Conference focuses on Infection, Immunity and Vaccines
Dr. Joanne Turner, VP for Research
Texas Biomed is a proud partner of the Vaccine Development Center of San Antonio. More than 200 people gathered for the 8th Annual conference by the group which focuses on Infection, Immunity and Vaccines. Students and researchers who presented oral and poster presentations were from Texas Biomed, University of Texas at San Antonio, UT Health San Antonio, University of the Incarnate Word, and the University of Texas Medical Branch in Galveston. Texas Biomed VP for Research, Professor Joanne Turner, Ph.D., serves as Executive Director of the Vaccine Development Center. 

New Podcasts
TXBioBytes from Texas Biomed


                         Texas Biomed: The Next Generation

Wendy Rigby
Media and Communications Specialist
8715 W. Military Dr., San Antonio, TX 78227